Prevalence of Diabetes and Other Cardiovascular Risk Factors in Patients Received at the COVID-19 Screening Center of Donka University Hospital, Guinea  

作　　者：Diallo Mamadou Alpha Diallo Mamadou Dian Mamoudou Bah El’Hadj Zainoul Kake Amadou Diallo Alpha Mamadou Cherif Ibrahima Sory Balde Djamilatou Diallo Mamadou Cherif Barry Mody Abdoullaye Diallo Amatoullaye Bah Kadidiatou Diallo Abdoul Mazid Balde Maimouna Sonna Bah Amadou Dieng Kadidja Diallo Mamadou Alpha;Diallo Mamadou Dian Mamoudou;Bah El’Hadj Zainoul;Kake Amadou;Diallo Alpha Mamadou;Cherif Ibrahima Sory;Balde Djamilatou;Diallo Mamadou Cherif;Barry Mody Abdoullaye;Diallo Amatoullaye;Bah Kadidiatou;Diallo Abdoul Mazid;Balde Maimouna Sonna;Bah Amadou;Dieng Kadidja(Department of Endocrinology, Metabolic Diseases and Nutrition, Donka University Hospital, Conakry, Guinea;Faculty of Health Sciences and Technology, Gamal Nasser University of Conakry, Conakry, Guinea;Ministry of Health and Public Hygiene, National Program for the Fight Against Non-Communicable Diseases, Conakry, Guinea;World Health Organization, Conakry, Guinea;Labe Regional Hospital, Conakry, Guinea)

机构地区：[1]Department of Endocrinology, Metabolic Diseases and Nutrition, Donka University Hospital, Conakry, Guinea [2]Faculty of Health Sciences and Technology, Gamal Nasser University of Conakry, Conakry, Guinea [3]Ministry of Health and Public Hygiene, National Program for the Fight Against Non-Communicable Diseases, Conakry, Guinea [4]World Health Organization, Conakry, Guinea [5]Labe Regional Hospital, Conakry, Guinea

出　　处：《Open Journal of Endocrine and Metabolic Diseases》2024年第11期191-198,共8页内分泌与新陈代谢疾病期刊（英文）

摘　　要：The aim of this study was to determine the prevalence of diabetes and other cardiovascular risk factors (smoking, obesity and high blood pressure) and to evaluate the WHO Global Cardiovascular Risk Score in the population of people suspected of COVID-19 infection aged 40 years or older. Material and Methods: This was a descriptive cross-sectional study conducted at the Donka University Hospital from June 1 to July 4, 2020 on subjects received for COVID-19 screening. Results: The prevalence of diabetes in patients suspected of COVID-19 was 7.8% comprising 1.2% of known diabetics and 6.8% of new cases. The prevalence of active smoking was 14.0%. That of sedentary lifestyle and obesity were 10.6% and 17.2% respectively. We found a prevalence of hypertension estimated at 45%, it was unknown in 76.47% of cases. In this series, 33.2% of patients had a high and very high cardiovascular risk (WHO scores). Conclusion: This study reveals a fairly high prevalence of diabetes and other cardiovascular risk factors in the population of people suspected of COVID-19. This observation should lead to the implementation of effective strategies for the prevention of non-communicable diseases in Guinea.The aim of this study was to determine the prevalence of diabetes and other cardiovascular risk factors (smoking, obesity and high blood pressure) and to evaluate the WHO Global Cardiovascular Risk Score in the population of people suspected of COVID-19 infection aged 40 years or older. Material and Methods: This was a descriptive cross-sectional study conducted at the Donka University Hospital from June 1 to July 4, 2020 on subjects received for COVID-19 screening. Results: The prevalence of diabetes in patients suspected of COVID-19 was 7.8% comprising 1.2% of known diabetics and 6.8% of new cases. The prevalence of active smoking was 14.0%. That of sedentary lifestyle and obesity were 10.6% and 17.2% respectively. We found a prevalence of hypertension estimated at 45%, it was unknown in 76.47% of cases. In this series, 33.2% of patients had a high and very high cardiovascular risk (WHO scores). Conclusion: This study reveals a fairly high prevalence of diabetes and other cardiovascular risk factors in the population of people suspected of COVID-19. This observation should lead to the implementation of effective strategies for the prevention of non-communicable diseases in Guinea.

关 键 词：DIABETES Risk Factors COVID-19 Cardiovascular Risk Score 

分 类 号：R58[医药卫生—内分泌]